Reme-D raises $1.4M pre seed
Announced 24 July 2026
◆ The Round
Reme-D raised $1.4M in pre seed funding, announced on 24 July 2026, led by Anara Impact Capital, with participation from Global Innovation Fund, Africa Health Ventures. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Reme-D
Egyptian healthtech startup that develops and manufactures molecular diagnostic tests for diseases including tuberculosis, HIV, hepatitis, and HPV. Reme-D is based in Egypt and currently at pre seed stage, operating in healthtech, diagnostics.
◆ Investors
LeadAnara Impact Capital
ParticipationGlobal Innovation Fund, Africa Health Ventures
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Reme-D's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Reme-D raise?
Reme-D raised $1.4M in its pre-seed round, announced 2026-07-24.
Who invested in Reme-D's pre-seed round?
The round was led by Anara Impact Capital, with participation from Global Innovation Fund and Africa Health Ventures.
What does Reme-D do?
Egyptian healthtech startup that develops and manufactures molecular diagnostic tests for diseases including tuberculosis, HIV, hepatitis, and HPV.
Verified 24 July 2026 · Sources: public filings